周大福(01929.HK)上季零售值按年增長46.1% 內地及港澳同店銷售均呈增長
周大福(01929.HK)公布,截至去年12月底止第三季度,零售值按年增長46.1%,其中內地零售值按年增長42.2%,佔集團零售值84.2%;香港、澳門及其他市場零售值按年增長70.8%,佔集團零售值15.8%。
內地同店銷售按年增長22.7%,香港及澳門同店銷售按年增長66.6%。兩個市場的同店銷售均有增長,主要受惠於節日需求及有利的比較基數。
去年12月30日至今年1月1日的三天元旦假期期間,內地的節日需求持續釋放,集團的內地零售值按年增長約60%。
於2024財年首九個月,集團於內地淨開設232個周大福珠寶零售點,於港澳及其他市場淨開設9個。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.